4XT.DE Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (11 lapkr. 2022 @ 18:35):

Stats
Dzisiejszy wolumen	1 452.00
Średni wolumen	2 758.00
Kapitalizacja rynkowa	0.00
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-2.18
ATR14	€0 (0.00%)

XPhyto Therapeutics Corp. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

XPhyto Therapeutics Corp. Finanse

Annual	2021
Przychody:	€286 498
Zysk brutto:	€199 478 (69.63 %)
EPS:	€-0.197

FY	2021
Przychody:	€286 498
Zysk brutto:	€199 478 (69.63 %)
EPS:	€-0.197

FY	2020
Przychody:	€345 654
Zysk brutto:	€0.00 (0.00 %)
EPS:	€-0.300

FY	2019
Przychody:	€208 119
Zysk brutto:	€0.00 (0.00 %)
EPS:	€-0.170

Financial Reports:

No articles found.

XPhyto Therapeutics Corp.

XPhyto Therapeutics Corp. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.